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Strain 2 and strain 13 guinea pigs were vaccinated with Mycobacterium bovis BCG and placed on low-protein
or protein-adequate diets. Five weeks later all animals were infected by the respiratory route with virulent
Mycobacterium tuberculosis H37Rv organisms. Four weeks postchallenge, guinea pigs were skin tested with
purified protein derivative and sacrificed. Protein deficiency resulted in significant reductions in body weight
and thyimus weight and in an impairment in the ability to control the M. bovis BCG vaccine organisms and to
mount delayed hypersensitivity reactions. Protein deficiency also adversely affected the efficacy of the BCG
vaccine as demonstrated by the numbers of virulent organisms recovered in spleens and lungs. Strain
differences were observed in the number of leukocytes, thymus weight, and the responsiveness of blood
lymphocytes to purified protein derivative stimulation. In general, strain 13 guinea pigs responded more
dramatically to dietary insult than did their strain 2 counterparts. Protein deprivation completely abolished
BCG vaccine protection in the lungs and spleens of strain 13 animals and significantly reduced the protection
afforded to strain 2 animals. In both strains, the BCG vaccine protected normally nourished guinea pigs. There
was no significant difference between strains with respect to susceptibility to pulmonary infection with virulent
mycobacteria. Thus, diet and genetic pedigree each had a significant influence on BCG vaccine efficacy.
The efficacy of the bacillus Calmette-Guerin (Mycobacte-
rium bovis BCG) vaccine in the worldwide effort to control
tuberculosis has varied significantly depending on undeter-
mined factors specific for a particular population or region
(2, 3). One factor which may be associated with a lack of
protection by BCG vaccine is malnutrition, prevalent in the
same Third World populations in which tuberculosis is
common (3, 9, 18).
Specific dietary deficiencies in humans and experimental
animals have significant deleterious effects on cell-mediated
immune responses to infection (7). Protein deficiency is
accompanied by the loss of tuberculin hypersensitivity to
purified protein derivative (PPD) (8, 10, 22). Experiments
have shown increased numbers of virulent mycobacteria in
spleens and lungs of previously BCG-vaccinated, malnour-
ished animals challenged by the respiratory route with M.
tuberculosis (9, 11). In addition, numbers of lymphocytes
and lymphocyte proliferation after stimulation by a mitogen
in vitro were both reduced in protein-deprived animals (12).
Studies involving inbred strains of rabbits and mice have
focused previously on genetic aspects of the immune re-
sponse to mycobacterial infections (1, 4, 17). Differences
have been observed in the immune responses of the respec-
tive resistant and susceptible inbred strains of these animals.
Inbred mice have been used most extensively in this partic-
ular area (14). These studies have involved high-dose, intra-
venous injections of virulent Mycobacterium tuberculosis or
M. bovis BCG organisms, whereas most human tuberculosis
is transmitted by droplet nuclei via the respiratory route (4,
14). Also, all of the previous work relating protein deficiency
and BCG vaccine efficacy has been done with outbred
(Hartley strain) guinea pigs administered low-protein diets
and challenged by the respiratory route with virulent
* Corresponding author.
mycobacteria (9, 11). Two inbred strains of guinea pigs,
strains 2 and 13, have been used in studies of basic immune
responses and resistance to other infectious diseases (15,
16). Although these strains are generally accepted to differ
with respect to susceptibility to mycobacterial infection, the
literature contains no direct comparison of these two strains.
An experimental advantage of using inbred animals is that
one can hold other factors constant while separating two
distinct genetic groups within the same species. In addition,
the desirability of determining interactions between genetic
and nutritional components of the immune response to BCG
makes the use of inbred guinea pigs particularly relevant.
In this study, we have observed the effects of chronic,
moderate dietary protein deficiency on protection against
virulent M. tuberculosis H37Rv in BCG-vaccinated strain 2
and strain 13 guinea pigs after pulmonary challenge.
(This information was presented in part previously [M. K.
Cohen, R. A. Bartow, C. L. Mintzer, and D. N. McMurray,
Annu. Meet. Am. Soc. Microbiol. 1986, U24, p. 123].)
MATERIALS AND METHODS
Experimental animals. Male and female pathogen-free
strain 2 and strain 13 inbred guinea pigs weighing 150 to 250
g were obtained commercially (strain 2-2/CrlBR; Charles
River Breeding Laboratories, Wilmington, Mass.; strain 13;
Crest Caviary, Raywood, Calif.). The animals were housed
individually in polycarbonate cages on stainless steel grid
floors with stainless steel feeders. They were each provided
with water and food ad libitum. The guinea pigs of each
strain were randomly assigned to an experimental diet and to
either a vaccinated or nonvaccinated treatment. Body
weights were recorded weekly during the experiment.
Experimental diets. The experimental diets were both
designed to meet recommended nutritional requiretnents for
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guinea pigs (13). One purified diet was protein deficient (10%
ovalbumin), the purified control diet had an adequate
amount of protein (30% ovalbumin), and the third diet was
commercial guinea pig chow (Ralston Purina, St. Louis,
Mo.). The purified diets were maintained isocaloric by
inversely varying the cornstarch and ovalbumin levels. The
purified diets were obtained commercially (Dyets, Inc.,
Bethlehem, Pa.) and were prepared according to a previ-
ously published formulation (12). Before initiation of the
experimental diets, animals were weaned from their com-
mercial chow by first mixing 50% ground chow with 50%
control diet and subsequently reducing the proportion of
ground chow in the mixture over a period of 2 to 3 weeks.
Once the experimental diets were initiated, the animals on
low-protein diets and the control animals were fed daily with
the respective powder diets. The chow-fed guinea pigs were
also fed daily, but the commercial chow was given as pellets.
Sixteen guinea pigs were assigned to each of the three diets.
Food intake was monitored periodically during the study.
BCG vaccination. Half of the guinea pigs in each diet group
and strain were each vaccinated with 0.15 ml containing
approximately 106 viable M. bovis BCG vaccine organisms
(Copenhagen 1331, Statens Seruminstitut, Copenhagen,
Denmark) reconstituted with sterile physiologic saline. The
animals were vaccinated subcutaneously in the left inguinal
area 3 weeks before the start of experimental diets.
Respiratory challenge. All animals in the study were chal-
lenged by the respiratory route with virulent M. tuberculosis
H37Rv organisms (ATCC 27294; American Type Culture
Collection, Rockville, Md.) 5 weeks postvaccination and 2
weeks after the initiation of the experimental diets. The
challenge culture was a dilution of frozen inoculum (-70°C)
in sterile saline. According to a published procedure (9, 21),
the animals were placed in an aerosol exposure chamber and
infected. The concentration of M. tuberculosis H37Rv was
adjusted to result in the inhalation and retention of about 102
viable organisms per guinea pig. Randomly selected groups
of 18 animals were exposed simultaneously. This procedure
has been shown to result in uniform, reproducible infection
in all animals (21).
PPD skin tests. All animals were shaved on the right side
and injected intradermally with 0.1 ml of PPD (PPD-RT23;
Statens Seruminstitut) containing 100 tuberculin units.
These injections were done 24 h before sacrifice, and the
mean diameter of induration was measured at sacrifice.
Necropsy procedure. Four weeks after respiratory chal-
lenge (6 weeks after the start of experimental diets), all
guinea pigs were weighed, and their tuberculin reactions
were recorded. Then 1.5 to 2.0 ml of sodium pentobarbital
(Sleepaway; Fort Dodge Laboratories, Fort Dodge, Iowa)
was injected intramuscularly into each animal. The anesthe-
tized animals were exsanguinated by cardiac puncture with
heparinized 10-ml syringes. The thoracic and abdominal
cavities of each animal were opened aseptically, and the
thymus, spleen, right lower lobe of the lung, and subcutane-
ous BCG vaccination nodule were aseptically removed. All
of the organs were placed in sterile dishes and weighed. The
lungs, spleens, and vaccination nodules were each homoge-
nized separately in 2.0 ml of sterile saline in Teflon-coated
glass homogenizers. Appropriate 10-fold dilutions were
made and inoculated onto duplicate M7H1O (Difco Labora-
tories, Detroit, Mich.) agar plates, which were incubated at
37°C for 4 to 5 weeks. The plated organisms were counted as
colonies and expressed as the mean log10 viable M. tubercu-
losis H37Rv (lung and spleen) or M. bovis BCG (vaccination
nodule) organisms per gram of tissue. Previous experience
has shown that the lungs and spleens of BCG-vaccinated
animals no longer harbor detectable levels of viable BCG 9
weeks postvaccination.
By standard clinical procedures, total and differential
leukocyte counts were determined from blood samples from
each animal. Total serum protein concentrations were mea-
sured by the method of Lowry et al. (6) with a bovine serum
albumin standard.
Lymphocyte blastogenesis. Lymphocytes from blood were
separated by density gradient centrifugation and cultured
with tuberculin in vitro. The isolated lymphocytes were
suspended in RPMI 1640 medium containing 10% fetal
bovine serum-penicillin (100 U/ml)-streptomycin (100
,xg/ml)-2-mercaptoethanol (10 puM)-L-glutamine (2 mM) and
placed into wells (2 x 105 cells per well) of microtiter plates
(Falcon Microtest II; Becton Dickinson Labware, Oxnard,
Calif.). Triplicate cultures were stimulated with PPD
(Statens Seruminstitut) at final concentrations of 50, 25, and
12.5 Lg/ml. Control cultures without antigen were also
established. The cells were then incubated for 4 days at 37°C
in a 5% CO2 atmosphere. On the final day of incubation, the
cells were labeled for 6 h with 0.8 ,uCi of tritiated thymidine
(6.7 Ci/mmol; New England Nuclear Corp., Boston, Mass.).
The cultures were then harvested onto fiber glass filter disks
and counted in a liquid scintillation counter (LS8000; Beck-
man Instruments, Inc., Fullerton, Calif.). The data are
expressed as net uptake of tritiated thymidine (counts per
minute) of cells stimulated by the dilution ofPPD which gave
maximum response minus counts per minute in nonstim-
ulated cells from the same animal.
Statistical analysis. The analysis of variance was used to
test for the effects of the treatment variables (diet, strain,
and vaccination status) on the dependent variables. Mean
differences between treatment groups were tested for statis-
tical significance with Duncan's new multiple-range test (20)
only when the F test indicated reliable treatment effects. The
accepted level of probability was set at 95% for all tests.
RESULTS
Dietary influence on growth and lymphoid tissues. The
inbred guinea pigs responded to the diets in a fashion
consistent with previous results obtained in outbred
(Hartley) guinea pigs. Protein-deprived animals of both
strains exhibited significant reductions in total serum protein
levels (data not shown). In both strain 2 and strain 13
animals, the chronic administration of the protein-deficient
diet resulted in losses or very modest increases in body
weight at the time of sacrifice (Table 1). Vaccinated animals
of both inbred strains exhibited significantly greater weight
gains than their nonvaccinated counterparts in all three diet
groups. The only exception was the strain 13 animals fed the
low-protein diet. Also, strain differences were observed with
respect to body weight changes, in that the strain 2 guinea
pigs appeared to adapt better to the low protein diet than did
the strain 13 animals.
The thymus weights of nonvaccinated, protein-deprived
guinea pigs of both strains were significantly reduced com-
pared with control animals which, in turn, exhibited smaller
thymuses than chow-fed guinea pigs. Among vaccinated
animals, diet exerted an effect upon the thymus weights of
strain 13 but not strain 2 guinea pigs. In general strain 13
guinea pigs given chow had larger thymuses than their strain
2 counterparts, although there was no significant effect of
strain alone on this parameter.
A significant strain difference was observed with respect
to the number of leukocytes counted (Table 1). In each
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TABLE 1. Effect of guinea pig strain, diet, and BCG vaccination on growth, thymus weight, and leukocyte counts in animals challenged
with virulent M. tuberculosis H37Rv by the respiratory routea
Guinea pig strain and Body wt change (g) Thymus wt (g) Total WBC/mm3 (103)
dietary treatmentb Vacc NV Vacc NV Vacc NV
2
Low protein +18 ± 19* -46 ± 12* 0.43 ± 0.07* 0.29 ± 0.03* 5.25 ± 2.00* 3.31 ± 0.76*
Control +75 ± 24t +13 ± 24t 0.56 ± 0.05* 0.45 ± 0.06t 7.68 ± 0.03t 5.77 ± 1.90*t
Chow +210 ± 52t +174 ± 36t 0.43 ± 0.04* 0.60 ± 0.05t 5.18 ± 1.76* 5.46 ± 0.83t
13
Low protein -130 + 8* -66 ± 12* 0.31 ± 0.03* 0.28 ± 0.05* 6.75 ± 0.21* 6.60 ± 2.20*
Control +69 ± 13t -53 ± 11* 0.55 ± 0.08t 0.46 ± 0.04t 9.25 ± 1.03t 8.78 ± 2.16*
Chow +282 ± 69t +208 ± 29t 0.64 ± 0.02t 0.76 ± 0.05t 12.95 ± 1.50t 12.12 ± 5.63*
a Results are the means ± standard errors of the mean of three or four guinea pigs per treatment. Means denoted by the same superscript (*, t, or O) within each
vaccination treatment and strain are not significantly different (P > 0.05) according to Duncan's new multiple-range test. Vacc, Vaccinated guinea pigs; NV,
nonvaccinated guinea pigs; WBC, leukocytes.
b Animals were maintained on the experimental diets for a total of 6 weeks before sacrifice.
diet-vaccination treatment group, a significantly greater
number of leukocytes was seen in the strain 13 guinea pigs.
In general, leukocyte counts tended to be higher in vacci-
nated animals than in nonvaccinated animals, although the
vaccine term was not statistically significant.
Persistence of viable BCG in vaccination site. Figure 1
illustrates the influence of diet and guinea pig strain on the
number of viable BCG organisms recovered from the sub-
cutaneous vaccination nodule. Protein-malnourished ani-
mals of both strains harbored significantly more viable
vaccine organisms than chow-fed animals, with the control-
purified group failing in between. When the data were
summed across diet groups within each strain, there was an
overall significant difference between the number of viable
BCG organisms recovered from the two strains of guinea
pigs (P < 0.05), with strain 2 animals exhibiting higher viable
counts.
Effect of diet and inbred strain on tuberculin responses in
vivo and in vitro. Results of the tuberculin skin hypersensi-
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FIG. 1. Numbers of viable M. bovis BCG organisms recovered
from the subcutaneous vaccination nodules of strain 2 and strain 13
guinea pigs maintained on low-protein (LP), control (C), or chow(Ch) diets; means ± standard errors of the mean of three or four
animals per treatment; asterisks indicate significant difference from
the chow-fed group (P < 0.05).
tivity tests are illustrated in Fig. 2. In both strains, the guinea
pigs on the protein-deficient diets had very small or nonex-
istent dermal reactions to the 100-tuberculin-unit dose of
PPD. The effect of guinea pig strain on tuberculin reactions
was not significant. However, when the data were broken
out by strain and vaccination, strain 2 vaccinated animals
had greater average skin test reactions (12.8 ± 2.8 mm) than
the nonvaccinated guinea pigs (8.0 ± 2.3 mm), whereas no
clear pattern was observed in the strain 13 guinea pigs
(vaccinated, 11.8 + 2.1 mm; nonvaccinated, 12.2 + 1.9 mm).
In neither case were the differences statistically significant.
Results from the lymphocyte blastogenesis procedure,
measuring proliferative cell responses to tuberculin in vitro,
showed a strain difference for blood stimulated with PPD
(Fig. 3). The strain term was statistically significant (P <
0.05) when the results were summed across diet and vacci-
nation. Background counts were uniformly low (50 to 75
cpm) and were not different between treatments. Counts in
PPD-stimulated cultures were at least five times greater than
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FIG. 2. Delayed hypersensitivity reactions to 100 tuberculin
units of PPD in tuberculous strain 2 and strain 13 guinea pigs fed
low-protein (LP), control (C), or chow (Ch) diets; means ± standard
errors of the mean for six to eight animals per treatment; asterisks
indicate significant difference from the control or chow-fed group (P
< 0.05).
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FIG. 3. PPD-induced proliferation in vitro of blood lymphocytes
taken from tuberculous strain 2 and strain 13 guinea pigs fed
low-protein (LP), control (C), or chow (Ch) diets; results are
expressed as the net uptake of [3H]thymidine per 106 viable lym-
phocytes cultured.
STRAIN 2 STRAIN 13
FIG. 4. Numbers of viable M. tuberculosis H37Rv organisms
recovered from the spleens of BCG-vaccinated (V) and nonvac-
cinated (NV) strain 2 and strain 13 guinea pigs maintained on
low-protein (LP), control (C), or chow (Ch) diets and challenged by
the respiratory route; means ± standard errors of the mean of three
or four animals per treatment; asterisks indicate significant differ-
ences due to vaccination (P < 0.05).
in unstimulated cultures. In each diet-vaccination group,
lymphocytes from the strain 13 guinea pigs exhibited greater
maximum stimulation, although no significant effect of diet
was observed.
The data for vaccinated and nonvaccinated animals were
pooled for these two variables because the vaccine term was
not statistically significant.
Impact of diet and genetic background on BCG efficacy.
The protective efficacy of BCG vaccine was determined by
the number of virulent M. tuberculosis H37Rv organisms
quantitatively recovered from the spleen and lung 4 weeks
postchallenge. In the spleen (Fig. 4), diet and vaccination
each had a significant influence on the number of organisms
recovered. In both strains, the BCG-vaccinated animals on
the low-protein diets had significantly greater numbers of
organisms in the spleen than their control or chow-fed
counterparts, suggesting that malnutrition negatively af-
fected the efficacy of the BCG vaccine. A significantly
greater number of organisms was recovered from the
nonvaccinated control and chow-fed guinea pigs compared
with the vaccinated animals, indicating a positive effect of
the BCG vaccine in those two groups. In the lungs (Fig. 5),
BCG appeared to be effective in that significantly fewer
virulent mycobacteria were recovered from the lungs of the
vaccinated animals in most strain-diet groups. One notable
exception was the low-protein strain 13 group, in which no
significant difference was observed between the vaccinated
and the nonvaccinated animals in either tissue, indicating no
protection afforded by BCG vaccination. As in the spleen,
more organisms were recovered from the lungs of the
BCG-vaccinated guinea pigs on the protein-deficient diets
than from the animals on the protein-adequate diets, indicat-
ing a definite nutritional effect on vaccine efficacy. The
overall effect of strain on the numbers of virulent mycobac-
teria recovered from lungs and spleens was not statistically
significant.
DISCUSSION
In this study we have demonstrated that the M. bovis BCG
vaccine protects normally nourished strain 2 and strain 13
inbred guinea pigs against virulent respiratory challenge by
M. tuberculosis H37Rv. In both the spleen and the lungs,
significantly smaller numbers of organisms were recovered
from the vaccinated animals (Fig. 4 and 5). This indicates
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FIG. 5. Numbers of viable M. tuberculosis H37Rv organisms
recovered from the lungs of BCG-vaccinated (V) and nonvaccinated
(NV) strain 2 and strain 13 guinea pigs maintained on low-protein
(LP), control (C), or chow (Ch) diets and challenged by the
respiratory route; means + standard errors of the mean of three or
four animals per treatment; asterisks indicate significant differences
due to vaccination (P < 0.05).
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318 COHEN ET AL.
protection by the vaccine at both the site of primary implan-
tation (the lungs), as well as in the spleen, which is seeded
with mycobacteria by hematogenous dissemination from the
lung during development of the infection (5).
We observed no significant differences between strain 2
and strain 13 guinea pigs in susceptibility of the normally
nourished animals to the virulent aerosol challenge. The two
strains responded to protein deprivation similarly in several
ways, including weight loss or very small weight increases
(Table 1) and weak reactions to tuberculin (Fig. 2). The latter
indicates a definite impairment of the cell-mediated compo-
nent of the immune system in these malnourished animals (9,
11, 12). This relative tuberculin anergy in protein-deficient
guinea pigs was even more dramatic when contrasted with
the increased number of viable BCG organisms recovered
from the vaccination site (Fig. 1). In spite of the prolonged
antigenic stimulation provided by vaccine organisms, pro-
tein-deprived guinea pigs could not mount or express a
significant delayed cutaneous reaction to PPD. The efficacy
of the BCG vaccine appeared to be adequate in the normally
nourished animals regardless of the strain as evidenced by
the significant differences in the numbers of virulent organ-
isms recovered from the spleens and lungs between the
vaccinated and the nonvaccinated animals.
However, several distinct differences were observed be-
tween the strain 2 and strain 13 guinea pigs. The strain 13
animals appeared to be more severely affected by the low-
protein diet as indicated by more drastic weight loss. It may
be that the strain 13 guinea pigs are less adaptable metabol-
ically to these diets, or that their cumulative food consump-
tion was reduced over the course of the experiment. Periodic
measurement of daily intake demonstrated no significant
difference between strains. The thymuses of strain 13 ani-
mals appeared to be very sensitive to dietary insult, as even
the modest caloric deficiency noted in the control group was
sufficient to cause reductions in thymus weight in that strain.
The total number of leukocytes counted in strain 13 animals
greatly outnumbered that in their strain 2 counterparts
(Table 1). The proliferative responses of blood lymphocytes
stimulated by PPD in vitro were also greater in the strain 13
guinea pigs (Fig. 3). Finally, the protein-deficient diet re-
duced or abolished the protective efficacy of the BCG
vaccine in both strains (Fig. 4 and S). Differences in the
numbers of virulent M. tuberculosis organisms recovered
between the vaccinated and the nonvaccinated animals were
substantially diminished in the animals on the low-protein
diets. Loss of BCG vaccine efficacy was more pronounced in
the malnourished strain 13 guinea pigs, but was similar to
that observed previously in outbred (Hartley) guinea pigs
studied under identical conditions (9, 11).
Other findings of this study are also consistent with
previous work in outbred (Hartley) guinea pigs; e.g., the
inbred animals were also adequately protected by the BCG
vaccine when properly nourished (9, 11), but exhibited
significant weight losses and tuberculin anergy when main-
tained on the protein-deficient diet (8, 9, 11).
Although it is commonly thought that these two inbred
strains of guinea pigs differ in susceptibility to tuberculosis,
as do some strains of inbred mice (4, 14), we have not found
sufficient evidence to support this contention. In addition,
one must be careful in comparing this study to previous work
done with inbred strains of rabbits or mice. We have
attempted to simulate human tuberculosis as closely as
possible, whereas in much of the previous work with other
species the experimental protocol has been relatively artifi-
cial. The animals in this study were infected via the respira-
tory route with M. tuberculosis organisms, consistent with
transmission of the disease in human populations. In con-
trast, the murine and rabbit studies have involved intrave-
nous or aerosol injections of relatively high doses of BCG or
M. tuberculosis organisms, respectively (1, 17, 19). These
factors should be taken into account when comparing the
results of the present study to previous investigations of the
role of genetics in resistance to mycobacteria.
Since well-nourished strain 2 and strain 13 guinea pigs
responded similarly with respect to BCG vaccine efficacy
and PPD hypersensitivity reactions, the decision as to which
strain to use in future experiments of this kind may be based
upon other criteria such as availability, cost, adaptability to
the diets, etc. Inbred guinea pigs will be quite useful be-
cause, like the Hartley strain, they have been used success-
fully to reproduce the conditions relevant to the interaction
between tuberculosis and malnutrition in humans. The in-
bred strains will be particularly advantageous in syngeneic
cell transfer and coculture experiments (15). Inbred strains
will be helpful in differentiating hereditary and environmen-
tal factors which have an impact on the influence of diet on
the immune response to tuberculosis. These studies may
eventually contribute to the control of tuberculosis in mal-
nourished human populations.
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